Seema Kalra

2.7k citations
24 papers · 429 indexed · h-index 8
Topics
Multiple Sclerosis Research Studies (17 papers)Systemic Lupus Erythematosus Research (4 papers)Systemic Sclerosis and Related Diseases (3 papers)

In The Last Decade

Seema Kalra

21 papers receiving 422 citations

Peers

Seema Kalra
Comparison fields: 5 of 58
  • Ophthalmology 166
  • Pathology and Forensic Medicine 161
  • Rheumatology 119
  • Neurology 113
  • Immunology 78
Replace Melike Mutlu with:
Melike Mutlu Türkiye
Erkingül Shugaiv Türkiye
Adnan Al-Araji Iraq
K.P. Wandinger Germany
Sasitorn Siritho Thailand
Andrew G. Murchison United Kingdom
Pavel Hradílek Czechia
Lisa Federle Italy
Fabio Brusaferri Italy
Guillaume Mathey France
Seema Kalra relative to Melike Mutlu Türkiye Melike Mutlu's profile →
Citations per field
00.5×3.9×
Melike Mutlu · 1×
Citations per year

Countries citing papers authored by Seema Kalra

Since Specialization
Citations

This map shows the geographic impact of Seema Kalra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seema Kalra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seema Kalra more than expected).

Fields of papers citing papers by Seema Kalra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seema Kalra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seema Kalra. The network helps show where Seema Kalra may publish in the future.

Co-authorship network of co-authors of Seema Kalra

This figure shows the co-authorship network connecting the top 25 collaborators of Seema Kalra. A scholar is included among the top collaborators of Seema Kalra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seema Kalra. Seema Kalra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 1
5 7
6 1
7 2
8 2
9 1
10 11
11 2
12 4
13 2
14 31
15 58
16 61
17 16
18 2
19 192
20 3

About Seema Kalra

Seema Kalra is a scholar working on Pathology and Forensic Medicine, Neurology and Ophthalmology, having authored 24 papers that have together received 429 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (17 papers), Systemic Lupus Erythematosus Research (4 papers) and Systemic Sclerosis and Related Diseases (3 papers). The work is most often cited by research in Ophthalmology (166 citations), Pathology and Forensic Medicine (161 citations) and Rheumatology (119 citations). Seema Kalra has collaborated with scholars based in United Kingdom, United States and Tunisia. Frequent co-authors include Cris S. Constantinescu, Adnan Al-Araji, John Curnow, H. Houman, Alan J. Silman, Afshin Borhani‐Haghighi, Alfred Mahr, Saeed Bohlega, Carlo Salvarani and Aksel Sıva. Their work appears in journals such as Brain Behavior and Immunity, Quality of Life Research and Journal of the Neurological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026